Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...

including smaller research labs and institutions with limited budgets. This could lead to an expansion of 10x Genomics' market share and help offset some of the challenges faced in other product ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...

The Chromium Xo, being more affordable than some of the company's other offerings, could attract a broader customer base, including smaller research labs and institutions with limited budgets. This ...

Coupled with the invalidation of 10x Genomics’ 10,155,981 patent last ... expanded into a new headquarters and state-of-the-art laboratory. To learn more, please visit https ...